Actemra 162 MG/0.9 ML syringe 0.9ML
Ended Awarded
- Contract number
- SPE2DB25FX04H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,051
Award facts
- Contract value 100% obligated
- $8,050.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $8,050.62 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 mL syringes. The contract, which is a non-set-aside award, was executed on June 18, 2025, with an ultimate completion date of June 20, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.999 billion and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for the Defense Health Agency and other military healthcare systems.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies a broad portfolio of pharmaceutical products and medical supplies to federal agencies. The company's extensive contract awards with the DLA demonstrate its capability to fulfill diverse medical procurement requirements through open competition, with previous deliveries encompassing specialty medications, generic drugs, vaccines, and medical devices across multiple therapeutic domains. This award reflects AmerisourceBergen's critical role in supporting military healthcare logistics and the company's established position as a key vendor within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FX04H?
SPE2DB25FX04H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 18, 2025.
How much is contract SPE2DB25FX04H worth?
The government has obligated $8,051 on SPE2DB25FX04H.
Is contract SPE2DB25FX04H an order under another contract?
Yes. SPE2DB25FX04H is a delivery order under SPE2DB20D2200, an indefinite delivery contract.
Was contract SPE2DB25FX04H competed?
The extent of competition for SPE2DB25FX04H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award